Plasma Cell precursor and Other Disorders
Outcomes of incorporating IV Daratumumab for the treatment of AL amyloidosis in real world patients from a multicenter registry in Latin America
Erika Barbara Brulc, Md
Staff
Hospital Italiano de Buenos Aires
Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina